Epizyme (EPZM) Struts Back To Wall Street, Plans $140 Million Raise
1/27/2014 8:06:02 AM
Epizyme saw its stock jump up a few weeks ago after hitting a milestone in its big partnership with Celgene. Now it plans to use some of that momentum to raise some more cash from public investors. On Monday morning, Cambridge, MA-based Epizyme (NASDAQ: EPZM) filed papers with the Securities and Exchange Commission showing it plans to raise as much as $140 million in cash through a public offering of stock.
Help employers find you! Check out all the jobs and post your resume.
comments powered by